| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/01/2001 | WO2001007584A1 Controlled electroporation and mass transfer across cell membranes |
| 02/01/2001 | WO2001007583A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | WO2001007569A1 Protecting pancreatic beta-cells during islet isolation; assessing islet viability and candidate diabetes drugs after islet isolation |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007479A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007458A1 lacR |
| 02/01/2001 | WO2001007451A2 Isolation of biomolecules |
| 02/01/2001 | WO2001007352A1 Device for observing and controlling one or more textile yarns by a succession of numerical photographs |
| 02/01/2001 | WO2001007160A2 Two-part microplate comprising thin-well insert and related fabrication method |
| 02/01/2001 | WO2001007159A2 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | WO2001007088A2 Methods for treating therapy-resistant tumors |
| 02/01/2001 | WO2001007087A2 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | WO2001007081A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 02/01/2001 | WO2001007070A1 Method for measuring coagulant factor activity in whole blood |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007061A1 Whole cell assay |
| 02/01/2001 | WO2001007030A2 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs |
| 02/01/2001 | WO2001006990A2 Use of etodolac to treat cancer |
| 02/01/2001 | WO2001006932A1 Device for monitoring fertility in women by observing physical changes in body fluids |
| 02/01/2001 | WO2000068415A3 A method for measuring biomolecules |
| 02/01/2001 | WO2000067735A3 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000063736A3 Optical microscopy and its use in the study of cells |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000061728A3 Human elastase i |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000058503A3 Improved method for detecting micro-organisms |
| 02/01/2001 | WO2000058405A3 Squaraine dyes |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000055624A3 Elisa kit for the determination of metabolic phenotypes |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000052479A3 Diagnostics and therapeutics for drusen associated ocular disorders |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000033076A9 Diagnosis of human glycosylation disorders |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000008138A3 Ribosomal rna (rrn) operon altered bacteria and uses thereof |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | DE19935766A1 Verfahren zur optischen Anregung von Fluorophor-markierter DNA und RNA A method for optical excitation of the fluorophore-labeled DNA and RNA |
| 02/01/2001 | DE19935165A1 Verfahren und Anordnung zur Konzentrationsbestimmung von Glucose in einer Körperflüssigkeit Method and apparatus for determining the concentration of glucose in a body fluid |
| 02/01/2001 | DE19919499C1 Verfahren zur Bestimmung anorganischer Bestandteile in einer Beschichtung eines Substrates Method for the determination of inorganic constituents in a coating of a substrate |
| 02/01/2001 | DE19846487C2 Meßsonde für die Detektion der Momentankonzentrationen mehrerer Gasbestandteile eines Gases Probe for detecting the instantaneous concentrations of a plurality of gas constituents of a gas |
| 02/01/2001 | CA2718926A1 Methods of reducing microbial resistance to drugs |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380307A1 Luminescence detection workstation |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380238A1 Homogeneous fluorescence method for assaying structural modifications of biomolecules |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380179A1 Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof |
| 02/01/2001 | CA2379927A1 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | CA2379836A1 System for microvolume laser scanning cytometry |
| 02/01/2001 | CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2379237A1 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | CA2379127A1 Immunoassay method of environmental contaminants |
| 02/01/2001 | CA2378898A1 Method for measuring coagulant factor activity in whole blood |
| 02/01/2001 | CA2378569A1 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 02/01/2001 | CA2378528A1 Computer-assisted formulation of culture media |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2378371A1 Use of etodolac to treat cancer |
| 02/01/2001 | CA2378110A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | CA2376969A1 A method of controlling the temperature of a specimen in or on a solid support member |
| 02/01/2001 | CA2375650A1 Ehrlichia canis genes and vaccines |
| 02/01/2001 | CA2375606A1 Spatially-encoded analyte detection |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 02/01/2001 | CA2345322A1 Device for monitoring fertility in women by observing physical changes in body fluids |
| 01/31/2001 | EP1072891A2 Detection of irreversible damage to IgG antibodies |
| 01/31/2001 | EP1072890A2 Method for the detection of prostate cancer |
| 01/31/2001 | EP1072889A1 Method for assaying creatine kinase isozyme activity and assay reagent |
| 01/31/2001 | EP1072888A2 Immunoassay method and reagent for HIV-1p24 antigen |
| 01/31/2001 | EP1072887A2 Immunoassay |
| 01/31/2001 | EP1072885A2 Apparatus for measuring the moisture of cereals |
| 01/31/2001 | EP1072879A2 Method and equipment for the determination of general and capillary viscosity of blood |
| 01/31/2001 | EP1072692A2 Method and assembly for assessing quality of a coating process |
| 01/31/2001 | EP1072687A2 Method for testing metastatic potential and method for screening compounds with metastasis-suppressing activity |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1072272A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 01/31/2001 | EP1072222A2 Method and apparatus for determination of glucose concentration in body fluid |
| 01/31/2001 | EP1072006A1 Expert system for analysis of dna sequencing electropherograms |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071958A1 Methods for substrate-ligand interaction screening |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071956A1 Assays for autoantibodies |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071954A1 Comb-like solid phase for measuring analytes |